SCHEMBL1225544

SCHEMBL1225544

Nc1ccc(C(F)(F)F)c(-c2ccncc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.49
KIF11 P52732 1/20 0.42
ADORA2A P29274 4/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK14 Q16539 4/20 0.38
MAPK13 O15264 3/20 0.38
MAPK12 P53778 3/20 0.38
MAPK11 Q15759 3/20 0.38
BACE1 P56817 2/20 0.38
SRC P12931 1/20 0.37
BRAF P15056 1/20 0.37
KDR P35968 1/20 0.37
RAF1 P04049 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
S1PR1 P21453 1/20 0.35
TDO2 P48775 1/20 0.35
MAPK10 P53779 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL901582 0.76 ADORA2B (0.57) ADORA2BADORA2AMAPK14MAPK13MAPK12
SCHEMBL18039107 0.73 ADORA2B (0.68) ADORA2BADORA2AALDH1A1KMT2AMAPK14
SCHEMBL19837870 0.72 ADORA2B (0.49) ADORA2BADORA2AALDH1A1KMT2AMAPK14
SCHEMBL22323484 0.71 RPS6KA3 (0.41) ADORA2BKDM4EALDH1A1KMT2ABACE1
SCHEMBL30519765 0.71 AXL (0.41) ADORA2AKDR
SCHEMBL26025615 0.71 AXL (0.41) ADORA2AKDR
SCHEMBL24360872 0.71 BACE1 (0.48) ADORA2AKDM4EALDH1A1BACE1S1PR1
SCHEMBL30115293 0.70 TRPV1 (0.54) KIF11
SCHEMBL22117225 0.70 BACE1 (0.40) ADORA2BKDM4EALDH1A1KMT2ABACE1
SCHEMBL22323259 0.69 CYP1A2 (0.43) KDM4EALDH1A1KMT2ABACE1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012661-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS PROTEIN KINASE MODULATORS NOVARTIS AG (CH) 2011-02-03 WO disclosed